Source: Pediatric Blood and Cancer. Conference titles: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FM
Subjects: NEOPLASIAS DO SISTEMA NERVOSO, GLIOMA (TERAPIA;DIAGNÓSTICO), CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EPELMA, S. et al. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG). Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/pbc.25715/epdf. Acesso em: 21 maio 2024. , 2015APA
Epelma, S., Odone, V., Gorender, E., Medeiros, R. S. S., & Silva, L. (2015). Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG). Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1002/pbc.25715/epdfNLM
Epelma S, Odone V, Gorender E, Medeiros RSS, Silva L. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG) [Internet]. Pediatric Blood and Cancer. 2015 ; 62 S274.[citado 2024 maio 21 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pbc.25715/epdfVancouver
Epelma S, Odone V, Gorender E, Medeiros RSS, Silva L. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG) [Internet]. Pediatric Blood and Cancer. 2015 ; 62 S274.[citado 2024 maio 21 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pbc.25715/epdf